Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ARL17A |
| Upstream (Parents) |
|---|
| (<<) ARHGAP29 → ARL17A |
| (<<) C2orf67 → ARL17A |
| (<<) LOC644397///LRRC37A2///LRRC37A3///LRRC37A4///LRRC37A → ARL17A |
| (<<) ZNF580 → ARL17A |
| (<<) ALMS1 → ARL17A |
| (<<) GNB5 → ARL17A |
| Downstream (Children) |
|---|
| ARL17A → ZNF484 (>>) |
| ARL17A → MAPK8IP3 (>>) |
| ARL17A → PQLC2 (>>) |
| ARL17A → BRS3 (>>) |
| ARL17A → IL7 (>>) |
| ARL17A → ZNF580 (>>) |
| ARL17A → MYBPH (>>) |
| ARL17A → MORC1 (>>) |
| ARL17A → ATP8A2 (>>) |
| ARL17A → LOC100289523///LOC392555 (>>) |
| ARL17A → PMP2 (>>) |
| ARL17A → ACCN4 (>>) |
| ARL17A → DPP6 (>>) |
| ARL17A → SPTLC3 (>>) |
